Trump signs experimental-drug bill
Law allows terminally ill patients to try unproven treatments
WASHINGTON — President Donald Trump signed legislation Wednesday aimed at helping people with deadly diseases try experimental treatments, calling it a “fundamental freedom” that will offer hope and save lives.
Joined by families dealing with amyotrophic lateral sclerosis, also called Lou Gehrig’s disease, and other diseases, Trump signed the so-called Right to Try bill and said he never understood why the issue had lagged for years and Congress hadn’t acted sooner.
“There were no options. But now you have hope — you really have hope,” Trump said. He noted that “for many years, patients, advocates and lawmakers have fought for this fundamental freedom.”
The bill cleared the House last week after an emotional debate in which Republicans said it would help thousands of people in search of hope. Many Democrats said the measure was dangerous and would give patients false hope.
As Trump distributed pens after signing the bill, 8-yearold Jordan McLinn of Indianapolis, who suffers from muscular dystrophy, waited to embrace the president, drawing laughter in the auditorium when he put his elbow on the table and held up his chin. Trump hugged Jordan and kissed him on the forehead.
“He’s going to be fantastic,” the president told Jordan’s mother.
The president was joined by Health and Human Services Secretary Alex Azar, Food and Drug Administration Commissioner Scott Gottlieb and some of the bill’s allies in Congress, including Sens. Ron Johnson, R-Wis., and Joe Donnelly, D-Ind.
Trump had supported efforts to gain access to the treatments during his 2016 campaign. In his State of the Union address, he said people who are terminally ill shouldn’t have to travel “from country to country to seek a cure.”
The measure would give people diagnosed with life-threatening conditions who have exhausted treatment options the ability to gain access to unproven drugs without first getting permission from the FDA. New drugs normally undergo years of expensive testing before manufacturers seek and gain FDA approval to market them.
Opponents of the bill said it would empower “fly-by-night physicians” to offer false hope and ineffective drugs to patients desperate for treatment. They also said the bill created the incorrect impression that the FDA serves as a bottleneck that deprives dying patients of unproven options.
FDA figures show it approves 99 percent of the roughly 1,000 requests it receives from doctors annually for so-called compassionate use of such treatments. The process generally takes about four days, but permission can be granted immediately by phone in emergencies.
The bill was supported by the libertarian Goldwater Institute and the conservative Americans for Prosperity, which is backed by the wealthy brothers Charles and David Koch. The bill also offers some legal protections for pharmaceutical companies, doctors or others involved in providing the treatment.